Simplifying Global Compliance
FDA Extends Comment Period on Reclassification Rule
Devices & Diagnostics Letter
The FDA is giving devicemakers more time to comment on a proposed rule that would reclassify some devices as Class II and amend the regulations to establish special controls for others.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing